Search

everythinglearnresearchcommunity

for

Search:↓

The new gel formulation effectively delivers Finasteride for hair growth treatment without skin irritation.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Abrocitinib may effectively treat stubborn alopecia universalis.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

The research developed new fortilin protein constructs for potential heart disease treatments.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Sonidegib often causes hair loss, and LC-OCT helps identify early signs.

The treatment increased hair growth and thickness in patients with hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Biosimilars lower costs but don't significantly improve access.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

An arthritis drug helped a person with severe hair loss regrow their hair.

Setipiprant did not significantly improve hair growth in men with hair loss.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

JAK inhibitors offer new hope for treating severe alopecia areata.